ViThera Pharmaceuticals' Grant

ViThera Pharmaceuticals raised a round of funding on April 17, 2012. Investors include Johnson & Johnson.

ViThera Pharmaceuticals is a biotech company harnessing the synthetic potential of bacteria to produce therapeutic molecules within the body to develop a new treatment for Inflammatory Bowel Disease. …

Articles about ViThera Pharmaceuticals' Grant: